In-vitro dissolution testing is the most important technique to measure/study in-vivo efficacy of medicinal product. Accurate in-vitro dissolution methods are pivotal to secure correct exposure of the drug molecule in the body. A broad and holistic program regarding dissolution testing throughout the life cycle of medicines will be offered during the day. The meeting will focus on different aspects of dissolution testing including topics such as;
– Dissolution testing techniques for different formulation platforms
– In-vitro dissolution for in-vivo predictions
– Equipment used
– Regulatory landscape
Who should attend?
The meeting is of interest to anyone working with pharmaceutical production, development, research or quality control. The program has been generated in collaboration between the Sections for Drug Formulation and Drug Analysis within The Swedish Academy of Pharmaceutical Sciences. Lectures connected to different areas e.g. formulation design, analytical methods and correlation to biopharmaceutical behavior will be presented. The lectures will be given in English.
Preliminary program
Venue and date
The meeting will take place at AstraZeneca in Mölndal, October 20. The meeting starts at 09.20 hrs with registration from 09.00 hrs and will end at approximately 17 hrs.
Registration
The participation fee is 1500 SEK until August 31 thereafter 2500 SEK. All prices are excluding VAT. For information about the cancellation policy, cancellation insurance and VAT, please visit our website.
Partnership possibilities
We offer two levels of partnership.
Gold • 12 000 SEK
BENEFITS
• 1 free registration to the scientific program
• Exhibition
– Exhibition stand and space for roll-up
• Exposure:
– Exposure of logo during breaks in the scientific program
– Exposure of logo on the seminar website
Silver • 5 000 SEK
BENEFITS
• Exposure:
– Exposure of logo during breaks in the scientific program
– Exposure of logo on the website.
All prices are exluding VAT.
When you register Choose ”the correct level of partnership under Tillval/additional at the registration form.
Organising committee
Anders Karlsson, AstraZeneca
Jonas Fagerberg, Disruptive Materials
Sofia Mattsson, Umeå University
Johan Breitholtz, AstraZeneca
Further information
For information regarding the program please contact jenny.hagberg@lakemedelsakademin.se and for organizational questions, please contact veronica.helzel@lakemedelsakademin.se
Inlägget Dissolution Testing in Quality Control and Drug Development – from USP Vessels to Artificial Intelligence dök först upp på Läkemedelsakademin.